OSDI
Ocular Surface Disease Index
A widely used self-report measure of dry eye symptoms and their impact on vision-related function.
At a Glance
- Population
- Adults with dry eye disease or ocular surface symptoms
- Number of Items
- 12 items
- Instrument Type
- PROM
- Digital Administration Availability
- Suitable for self-report electronic administration
- Automated Scoring Availability
- Yes — defined transformation to a 0–100 severity score
- Suitable Use Settings
- Ophthalmology clinical care and dry eye clinical trials
About the Instrument
Developed by Schiffman and colleagues, the OSDI is copyrighted by Allergan and is one of the most widely used patient-reported measures of dry eye symptom severity.
What It Measures
Ocular symptoms, vision-related function, and environmental triggers associated with dry eye disease.
Digital Administration
Delivered electronically through the PROMinsight platform as part of a digital patient-reported outcomes workflow.
Scoring / Reporting
Item responses are summed and transformed to a 0–100 scale, with higher scores indicating greater disability related to dry eye.
Use in Research / Clinical Care / Clinical Trials
A standard patient-reported endpoint in dry eye disease clinical trials and ophthalmology practice.
Enquire About This Instrument
Interested in using the OSDI in your research, clinical programme or study? Contact PROMinsight to discuss access.
Enquire About This Instrument